The investigation provided insight into the distribution of MTAP deletion across diverse histological subtypes, revealing 50% adenocarcinomas, 42% squamous cell carcinomas, and 8% large cell carcinomas, from the set of samples analyzed. This evidence concerns the gene MTAP and adenocarcinoma.